Literature DB >> 1490105

Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium.

J Müthing1, A Pörtner, V Jäger.   

Abstract

Gangliosides of the 'GM1b-pathway' (GM1b and GalNAc-GM1b) have been found to be highly expressed by the mouse T lymphoma YAC-1 grown in serum-supplemented medium, whereas GM2 and GM1 ('GM1a-pathway') occurred only in low amounts [Müthing, J., Peter-Katalinić, J., Hanisch, F.-G., Neumann, U. (1991) Glycoconjugate J 8:414-23]. Considerable differences in the ganglioside composition of YAC-1 cells grown in serum-supplemented and in well defined serum-free medium were observed. After transfer of the cells from serum-supplemented medium (RPMI 1640 with 10% fetal calf serum) to serum-free medium (RPMI 1640 with well defined supplements), GM1b and GalNAc-GM1b decreased and only low amounts of these gangliosides could be detected in serum-free growing cells. The expression of GM1a was also diminished but not as strongly as that of GM1b and GalNAc-GM1b. These growth medium mediated ganglioside alterations were reversible, and the original ganglioside expression was achieved by readaptation of serum-free growing cells to the initial serum-supplemented medium. On the other hand, a 'new' ganglioside, supposed to represent GalNAc-GD1a and not expressed by serum-supplemented growing cells, was induced during serum-free cultivation, and increased strongly after readaptation. These observations reveal that the ganglioside composition of in vitro cultivated cells can be modified by the extracellular environment due to different supplementation of the basal growth medium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490105     DOI: 10.1007/bf00731138

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  38 in total

1.  Uptake and metabolism of gangliosides in transformed mouse fibroblasts. Relationship of ganglioside structure to choleragen response.

Authors:  P H Fishman; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

2.  Liposomes as model membranes for ligand-receptor interactions: studies with choleragen and glycolipids.

Authors:  P H Fishman; J Moss; R L Richards; R O Brady; C R Alving
Journal:  Biochemistry       Date:  1979-06-12       Impact factor: 3.162

3.  Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain.

Authors:  L Svennerholm; J E Månsson; Y T Li
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

4.  Incorporation of exogenous glycosphingolipids in plasma membranes of cultured hamster cells and concurrent change of growth behavior.

Authors:  R A Laine; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  1973-10-01       Impact factor: 3.575

5.  Changes in phospholipid and ganglioside during differentiation of mouse myeloid leukemia cells.

Authors:  M Saito; H Nojiri; M Yamada
Journal:  Biochem Biophys Res Commun       Date:  1980-11-28       Impact factor: 3.575

6.  "Neuraminidase-resistant" sialic acid residues of gangliosides.

Authors:  R Schauer; R W Veh; M Sander; A P Corfield; H Wiegandt
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

7.  Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors.

Authors:  V Jäger; J Lehmann; P Friedl
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

8.  Ganglioside alterations in stimulated murine macrophages.

Authors:  H C Yohe; D L Coleman; J L Ryan
Journal:  Biochim Biophys Acta       Date:  1985-08-08

9.  A new ganglioside showing choleragenoid-binding activity in mouse spleen.

Authors:  K Nakamura; M Suzuki; F Inagaki; T Yamakawa; A Suzuki
Journal:  J Biochem       Date:  1987-04       Impact factor: 3.387

10.  Ganglioside changes during cell aging in human diploid fibroblast TIG-1.

Authors:  T Ohsawa; Y Nagai
Journal:  Exp Gerontol       Date:  1982       Impact factor: 4.032

View more
  9 in total

1.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

2.  The structures of polysaccharides and glycolipids of Aspergillus fumigatus grown in the presence of human serum.

Authors:  M C Bahia; R P Vieira; B Mulloy; R Hartmann; E B Bergter
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.

Authors:  J Müthing; M Cacić
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

4.  Ingenious Action of Vibrio cholerae Neuraminidase Recruiting Additional GM1 Cholera Toxin Receptors for Primary Human Colon Epithelial Cells.

Authors:  Johanna Detzner; Charlotte Püttmann; Gottfried Pohlentz; Johannes Müthing
Journal:  Microorganisms       Date:  2022-06-20

5.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

6.  Expression of neutral glycosphingolipids and gangliosides in human skeletal and heart muscle determined by indirect immunofluorescence staining.

Authors:  M Cacić; J Müthing; I Kracun; U Neumann; S Weber-Schürholz
Journal:  Glycoconj J       Date:  1994-10       Impact factor: 2.916

7.  Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.

Authors:  M Cacic; K Sostarić; S Weber-Schürholz; J Müthing
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

8.  Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse.

Authors:  M El-Abbadi; T N Seyfried; A J Yates; C Orosz; M C Lee
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

9.  Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Julia S Schmitz; Daniel Steil; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2017-10-25       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.